Sangamo Therapeutics (NASDAQ: SGMO) disclosed:On May 13, 2019, Kathy Y. Yi notified Sangamo Therapeutics, Inc. (the “Company”) of her intention ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE